¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"hereditary material"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • hygroscopic material
    ¹°Èí¼ö¹°Áú
  • investing material
    ¸Å¸ôÀç, ÇǺ¹Àç
  • impression material
    ÀλóÀç
  • material
    1. Àç·á 2. ¹°Áú
  • material safety data sheet
    ¹°Áú¾ÈÀüÀÚ·á¿ëÁö
  • orthodontic material
    ±³Á¤¿ëÀç·á
  • prosthetic material
    Àΰø»ðÀÔ¹°Àç·á, º¸Çü¹°Àç·á
  • prosthetic material graft
    º¸Çü¹°À̽Ä
  • radio-opaque material
    ¹æ»ç¼±ºñÅõ°ú¹°Áú
  • raw material
    ¿ø·á
  • reference material
    Âü°í¹°Áú
  • radioactive material
    ¹æ»ç¼º¹°Áú
  • suture material
    ºÀÇÕÀç·á
  • silicone impression material
    ½Ç¸®ÄÜÀλóÀç
  • waste material
    Æó±â¹°
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • embolic material
    »öÀü¹°Áú
  • grinding material
    ¿¬¸¶Àç
  • prosthetic material graft
    º¸Ã¶¹°À̽Ä
  • hydrocolloidal impression material
    ¼ö¼ºÄÝ·ÎÀ̵åÀλóÀç
  • hygroscopic material
    Èí¼ö¼º¹°Áú
  • impression material
    ÀλóÀç
  • investing material
    ¸Å¸ôÀç, ÇǺ¹
  • material
    Áú, ¹°, Àç, ¹°Áú
  • material safety data sheet
    ¹°Áú¾ÈÀüÀÚ·á¿ëÁö
  • natural abrasive material
    õ¿¬¿¬»èÀç·á
  • orthodontic material
    ±³Á¤¿ëÀç·á
  • prosthetic material
    Àΰøº¸ÀåÀç·á
  • radio-opaque material
    ¹æ»ç¼±ºñÅõ°ú¹°Áú
  • radioactive material
    ¹æ»ç¼º¹°Áú
  • raw material
    ¿ø·á
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • hereditary disease
    À¯Àüº´.
  • hereditary disorder
    À¯Àü¼ºÀå¾Ö
  • hereditary disorder
    À¯Àü¼º Àå¾Ö<Áúº´>
  • hereditary ectodermal dysplasia
    À¯Àü¼º ¿Ü¹è¿±¼º ÀÌÇü¼ºÁõ(¡­èâÛÏç¨àõì¶û¡à÷ ñø).
  • hereditary ectodermal polydysplasia
    À¯Àü(¼º) ¿Ü¹è¿±¼º ´Ù¹ßÀÌÇü¼ºÁõ.
  • hereditary edema
    À¯Àü¼º ºÎÁ¾.
  • hereditary edema
    À¯Àü¼º ºÎÁ¾
  • hereditary effect
    À¯ÀüÀû¿µÇâ
  • hereditary elliptocytosis
    À¯Àü¼ºÅ¸¿ø±¸Áõ
  • hereditary enamel hypoplasia
    À¯Àü¼º ¹ý³¶ Áú ÀúÇü¼ºÁõ.
  • hereditary epilepsy
    À¯Àü¼º °£Áú(¡­ÊÖòð).
  • hereditary fragility of bone
    À¯Àü¼º °ñ Ãë¾àÁõ (¡­Íéöªå°ñø).
  • hereditary fragility of bone
    À¯Àü¼º °ñÃë¾àÁõ (¡­Íéöªå°ñø).
  • hereditary fructose intolerance
    À¯Àü¼º ÇÁ·èÅä¿À½º ºÒ³»Áõ(¡­ÝÕÒ±ñø).
  • hereditary glycinuria
    À¯Àü¼º ±Û¸®½Å´¢Áõ.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • hereditary angioedema
    À¯Àü¼º ¸Æ°üºÎÁ¾
  • hereditary angioedema
    À¯Àü¼ºÇ÷°üºÎÁ¾
  • hereditary aphasia
    À¯Àü(¼º) ½Ç¾î(Áõ).
  • hereditary ataxia
    À¯Àü(¼º) ¿îµ¿½ÇÁ¶.
  • hereditary benign intraepithelial dyskeratosis
    À¯Àü¼º ¾ç¼º »óÇdz» ÀÌ»ó°¢È­Áõ
  • hereditary brown enamel
    À¯Àü¼º °¥»ö ¹ý³¶Áú.
  • hereditary brown tooth
    À¯Àü¼º °¥»öÄ¡¾Æ.
  • hereditary bullous epidermolysis ³ª e.bullosa hereditaria
    À¯Àü¼º Ç¥ÇǼöÆ÷Áõ.
  • hereditary cerebellar ataxia
    À¯Àü¼º ¼Ò³ú¼º ¿îµ¿½ÇÁ¶.
  • hereditary cerebellar sclerosis
    À¯Àü¼º ¼Ò³ú°æÈ­Áõ.
  • hereditary cerebral hemorrhages with amyloidosis(hchwa)
    À¯Àü¼º ³úÃâÇ÷, ¾Æ¹Ð·ÎÀ̵åÁõ¼º
  • hereditary chorea
    À¯Àü(¼º) ¹«µµº´.
  • hereditary coagulation disorder
    À¯Àü¼º ÀÀ °íÀå¾Ö.
  • hereditary coproporphyria
    À¯Àü¼º ÄÚÇÁ·ÎÆ÷ ¸£ÇǸ®¾Æ.
  • hereditary corneal dystrophy
    À¯Àü¼º °¢¸·ÀÌ ¿µ¾çÁõ.
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
NSM neurosecretory material; neurosecretory motor neuron; nonantigenic specific mediator; nutrient sporu...
ORM orosomucoid; other regulated material; oxygen ratio monitor
POMP phase-offset multiplanar [pulse sequence in magnetic resonance imaging]; principal outer material pr...
PRM phosphoribomutase; photoreceptor membrane; premature rupture of membranes; Primary Reference Materia...
PXM projection x-ray microscopy; pseudoexfoliation material
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
SAM surface active material
AHO Albright hereditary osteodystrophy
CHED Congenital Hereditary Endothelial Dystrophy
HANE Hereditary Angio Neurotic Edema
HAE Hereditary Angio-Edema
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • reinforcing material
    º¸°­Á¦
    °­È­³ª Áõ°­À» ÀÏÀ¸Å°´Â ¹°Áú.
  • restorative material
    ¼öº¹ Àç·á
  • root canal filling material
    ±Ù°ü ÃæÀüÀç
  • self-sealing material
    ÀÚ°¡ ºÀ¼â¼º Àç·á
  • semifluid impression material
    ¹Ý À¯µ¿¼º ÀλóÀç
  • silicone impression material
    ½Ç¸®ÄÜ ÀλóÀç
  • soft resilient material
    ¿¬¼º ź¼ºÀç
  • suture material
    ºÀÇÕ Àç·á
  • synthetic material
    ÇÕ¼º ¹°Áú
  • target material
    Ÿ°Ù ¹°Áú
  • vasoexcitor material
    Ç÷°ü ¼öÃà ÀÎÀÚ
    ½ÇÇèÀû °íÇ÷¾ÐÀ» ÀÏÀ¸Å² °³ÀÇ ½ÅÁ¤¸Æ¿¡¼­ ¹ß°ßµÈ Á¤¸Æ ÀÚ±Ø ¹°Áú·Î, ¾Æµå·¹³¯¸°¿¡ ´ëÇØ Áö³ªÄ£ ¹ÝÀÀÀ» ³ªÅ¸³½´Ù.
  • waste material
    Æó±â¹°
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
hereditary hyperthyroidism A rare inherited (autosomal dominant) disorder with constitutive stimulation of the thyrocytes.
(05 Mar 2000)
hereditary hypertrophic neuropathy dejerine-Sottas disease
hereditary lymphedema Permanent pitting oedema usually confined to the legs; two types, congenital (Milroy's disease ), or with onset at about the age of puberty (Meige's disease ); autosomal dominant inheritance.
(05 Mar 2000)
hereditary methemoglobinaemia Methemoglobinaemia due to formation of any one of a group of abnormal a chain or b chain haemoglobins collectively known as haemoglobin M. Slate-gray cyanosis occurs in early infancy, without pulmonary or cardiac disease, and is resistant to ascorbic acid or methylene blue therapy; autosomal dominant inheritance, methemoglobinaemia due to deficiency of cytochrome b5 reductaseor methemoglobin reductase, the enzyme responsible for reduction of intraerythrocyte methemoglobin; cyanosis is improved by ascorbic acid or methylene blue; autosomal recessive inheritance, one case of methemoglobinaemia has been reported that apparently is due to a deficiency of cytochrome b5.
Synonym: hereditary methemoglobinaemia, hereditary methemoglobinaemic cyanosis, primary methemoglobinaemia.
(05 Mar 2000)
hereditary methemoglobinaemic cyanosis Methemoglobinaemia due to formation of any one of a group of abnormal a chain or b chain haemoglobins collectively known as haemoglobin M. Slate-gray cyanosis occurs in early infancy, without pulmonary or cardiac disease, and is resistant to ascorbic acid or methylene blue therapy; autosomal dominant inheritance, methemoglobinaemia due to deficiency of cytochrome b5 reductaseor methemoglobin reductase, the enzyme responsible for reduction of intraerythrocyte methemoglobin; cyanosis is improved by ascorbic acid or methylene blue; autosomal recessive inheritance, one case of methemoglobinaemia has been reported that apparently is due to a deficiency of cytochrome b5.
Synonym: hereditary methemoglobinaemia, hereditary methemoglobinaemic cyanosis, primary methemoglobinaemia.
(05 Mar 2000)
hereditary multiple exostoses A disturbance of enchondral bone growth in which multiple, generally benign osteochondromas of long bones appear during childhood, commonly with shortening of the radius and fibula; the ill-effects are usually mechanical but malignant change is rare; autosomal dominant inheritance.
Synonym: diaphysial aclasis, hereditary deforming chondrodystrophy, multiple exostosis, osteochondromatosis.
(05 Mar 2000)
hereditary multiple trichoepithelioma <tumour> Multiple small benign nodules, occurring mostly on the skin of the face, derived from basal cells of hair follicles enclosing small keratin cysts; frequent autosomal dominant inheritance.
Synonym: acanthoma adenoides cysticum, Brooke's tumour, epithelioma adenoides cysticum, hereditary multiple trichoepithelioma.
Origin: tricho-+ epithelioma
(05 Mar 2000)
hereditary mutation A gene change that occurs in a germ cell (an egg or sperm) to become incorporated in every cell in the body. Hereditary mutations (also called germline mutations) play a role in cancer as, for example, the eye tumour retinoblastoma and wilms' tumour of the kidney.
(12 Dec 1998)
hereditary myokymia A syndrome consisting of myokymia, hypoglycaemia, and disturbed thyroid function.
(05 Mar 2000)
hereditary nephritis <pathology> An inherited disorder involving damage to the kidneys, haematuria and hearing loss. In some individuals vision may also be affected. This genetic disease is uncommon.
Symptoms include loss of hearing, abnormal colour to urine, swelling, cough and decline in vision.
Inheritance: sex-linked autosomal dominant.
Incidence: 1 in 50,000.
(27 Sep 1997)
hereditary opalescent dentin Synonym: dentinogenesis imperfecta.
Synonym: opalescent dentin.
(05 Mar 2000)
hereditary pancreatitis <radiology> Rare, autosomal dominant, variable penetrance, onset often in childhood, on X-ray: large, round, peripherally dense calculi
(12 Dec 1998)
hereditary peroneal nerve dysfunction <neurology> A slowly progressive genetic disorder characterised by muscle atrophy in the feet and the legs, progressing to the hands and arms, due to a disorder involving the destruction of nerves (degeneration of the myelin sheath).
Other features include foot drop and a slapping gait. There is no specific treatment for this disorder.
(27 Sep 1997)
hereditary persistence of foetal haemoglobin <haematology> Hereditary persistence of foetal haemoglobin is a genetic condition where adult types of haemoglobin fail to develop and the types of haemoglobin the individual had as a foetus remains present well past the point when they would normally have stopped being produced.
(09 Oct 1997)
hereditary progressive arthro-ophthalmopathy Autosomal dominant arthro-ophthalmopathy associated with progressive multiple dysplasia of the epiphyses, overtubulation of long bones, cleft lip and palate, hypermobility of joints, flattened vertebral bodies, pelvic bone deformities, and deafness.
Synonym: Stickler's syndrome.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
ÅëÇÕ°Ë»ö ¿Ï·á